326 related articles for article (PubMed ID: 31672302)
21. Clinical characteristics of adrenocortical tumors in children.
Chen QL; Su Z; Li YH; Ma HM; Chen HS; Du ML
J Pediatr Endocrinol Metab; 2011; 24(7-8):535-41. PubMed ID: 21932594
[TBL] [Abstract][Full Text] [Related]
22. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
23. Computed tomography (CT) scan identified necrosis, but is it a reliable single parameter for discerning between malignant and benign adrenocortical tumors?
Garay-Lechuga D; Pérez-Soto RH; Hernández-Acevedo JD; Butrón-Hernández D; Sierra-Salazar M; Pantoja-Millán JP; Herrera MF; Velázquez-Fernández D
Surgery; 2022 Jan; 171(1):104-110. PubMed ID: 34183180
[TBL] [Abstract][Full Text] [Related]
24. Development of ipsilateral adrenocortical carcinoma sixteen years after resection of an adrenal tumour causing Cushing's syndrome.
Tan HS; Thai AC; Nga ME; Mukherjee JJ
Ann Acad Med Singap; 2005 Apr; 34(3):271-4. PubMed ID: 15902349
[TBL] [Abstract][Full Text] [Related]
25. A 12-year-old chinese girl with Cushing syndrome and virilization due to adrenocortical carcinoma.
Wong LM; Li CH; Chan OK; Shek CC; Kwong NS
J Pediatr Endocrinol Metab; 2011; 24(3-4):193-6. PubMed ID: 21648291
[TBL] [Abstract][Full Text] [Related]
26. Unusual adrenal cortical tumor of unknown biologic potential: a nodule in a nodule in a nodule.
Ranganathan S; Lynshue K; Hunt JL; Kane T; Jaffe R
Pediatr Dev Pathol; 2005; 8(4):483-8. PubMed ID: 16010500
[TBL] [Abstract][Full Text] [Related]
27. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
28. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
Nomura K; Saito H; Aiba M; Iihara M; Obara T; Takano K
Endocr J; 2003 Apr; 50(2):155-62. PubMed ID: 12803235
[TBL] [Abstract][Full Text] [Related]
29. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
30. Discerning malignancy in resected adrenocortical neoplasms.
Sasano H; Suzuki T; Moriya T
Endocr Pathol; 2001; 12(4):397-406. PubMed ID: 11914473
[TBL] [Abstract][Full Text] [Related]
31. [Childhood adrenocortical tumors: from a clinical to a molecular approach].
Antonini SR; Colli LM; Ferro L; Mermejo L; Castro Md
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):599-606. PubMed ID: 22218442
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
Wang C; Sun Y; Wu H; Zhao D; Chen J
Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
[TBL] [Abstract][Full Text] [Related]
33. Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas?
Flynt KA; Dillman JR; Davenport MS; Smith EA; Else T; Strouse PJ; Caoili EM
Pediatr Radiol; 2015 Jul; 45(8):1160-8. PubMed ID: 25794486
[TBL] [Abstract][Full Text] [Related]
34. Analysis of numerical chromosomal aberrations in adrenal cortical neoplasms by fluorescence in situ hybridization.
Shono T; Sakai H; Takehara K; Honda S; Kanetake H
J Urol; 2002 Oct; 168(4 Pt 1):1370-3. PubMed ID: 12352395
[TBL] [Abstract][Full Text] [Related]
35. Dissecting Morphological and Molecular Heterogeneity in Adrenocortical Carcinoma.
Duregon E; Volante M; Rapa I; Vatrano S; Papotti M
Turk Patoloji Derg; 2015; 31 Suppl 1():98-104. PubMed ID: 26177320
[TBL] [Abstract][Full Text] [Related]
36. RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights.
Di Dalmazi G; Altieri B; Scholz C; Sbiera S; Luconi M; Waldman J; Kastelan D; Ceccato F; Chiodini I; Arnaldi G; Riester A; Osswald A; Beuschlein F; Sauer S; Fassnacht M; Appenzeller S; Ronchi CL
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32875319
[TBL] [Abstract][Full Text] [Related]
37. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
Blanes A; Diaz-Cano SJ
Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
[TBL] [Abstract][Full Text] [Related]
38. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
[TBL] [Abstract][Full Text] [Related]
39. Cushing's syndrome due to a large adrenocortical adenoma with histological features simulating ACTH-independent macronodular adrenocortical hyperplasia.
Karasawa R; Hotta M; Aiba M; Takano K
Pathol Int; 2004 Apr; 54(4):273-8. PubMed ID: 15028030
[TBL] [Abstract][Full Text] [Related]
40. Analysis of circulating microRNAs in adrenocortical tumors.
Szabó DR; Luconi M; Szabó PM; Tóth M; Szücs N; Horányi J; Nagy Z; Mannelli M; Patócs A; Rácz K; Igaz P
Lab Invest; 2014 Mar; 94(3):331-9. PubMed ID: 24336071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
